10-n-nonylacridinium orange has been researched along with cuprizone in 1 studies
| Studies (10-n-nonylacridinium orange) | Trials (10-n-nonylacridinium orange) | Recent Studies (post-2010) (10-n-nonylacridinium orange) | Studies (cuprizone) | Trials (cuprizone) | Recent Studies (post-2010) (cuprizone) |
|---|---|---|---|---|---|
| 74 | 1 | 17 | 825 | 1 | 629 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cammer, W | 1 |
1 other study(ies) available for 10-n-nonylacridinium orange and cuprizone
| Article | Year |
|---|---|
The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro.
Topics: Acridine Orange; Animals; Animals, Newborn; Cell Count; Cell Differentiation; Cells, Cultured; Coculture Techniques; Coloring Agents; Cuprizone; Dose-Response Relationship, Drug; Immunohistochemistry; Mitochondria; Myelin Basic Protein; Neuroglia; Oligodendroglia; Rats; Rats, Sprague-Dawley; Time Factors | 1999 |